{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:03:44Z","timestamp":1772726624629,"version":"3.50.1"},"reference-count":32,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Griffith University School of Pharmacy and Medical Science"},{"name":"Gold Coast Hospital and Health Service Allied Health Research"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Policy and Practice"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/20523211.2024.2418367","type":"journal-article","created":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T16:51:01Z","timestamp":1732035061000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study"],"prefix":"10.1080","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-7379-8525","authenticated-orcid":false,"given":"Danielle","family":"Green","sequence":"first","affiliation":[{"name":"Gold Coast Hospital and Health Service","place":["Southport, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5889-1968","authenticated-orcid":false,"given":"Catherine","family":"Edmunds","sequence":"additional","affiliation":[{"name":"Gold Coast Hospital and Health Service","place":["Southport, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3677-0608","authenticated-orcid":false,"given":"Roselyn","family":"Rose\u2019Meyer","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Southport, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0498-4209","authenticated-orcid":false,"given":"Indu","family":"Singh","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Southport, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4553-743X","authenticated-orcid":false,"given":"H. Laetitia","family":"Hattingh","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Southport, Australia"]},{"name":"Allied Health Research, Gold Coast Health","place":["Southport, Australia"]},{"name":"The University of Queensland","place":["St Lucia, Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,11,19]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2015.4.20150375"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060898"},{"key":"e_1_3_5_4_1","unstructured":"Australian Medicines Handbook. (2023). AMH. https:\/\/amhonline.amh.net.au\/chapters\/blood-electrolytes\/anticoagulants\/heparins\/enoxaparin#enoxaparin-products."},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2016.06.789"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa575"},{"key":"e_1_3_5_7_1","volume-title":"The SAGE Handbook of Qualitative Research (Fifth edition ed.)","author":"Denzin N. K.","year":"2018","unstructured":"Denzin, N. K., & Lincoln, Y. S. (2018). The SAGE Handbook of Qualitative Research (Fifth edition ed.). SAGE."},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.2.181"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1177\/1525822X05279903"},{"key":"e_1_3_5_10_1","volume-title":"Heparin and LMW heparin: Dosing and adverse effects","author":"Hull R.","year":"2023","unstructured":"Hull, R., Garcia, D., & Burnett, A. (2023). Heparin and LMW heparin: Dosing and adverse effects. UpToDate."},{"issue":"8","key":"e_1_3_5_11_1","first-page":"Cd3","article-title":"Calculated decisions: HAS-BLED Score for major bleeding risk","volume":"21","author":"Hwang C.","year":"2019","unstructured":"Hwang, C. (2019). Calculated decisions: HAS-BLED Score for major bleeding risk. Emergency Medicine Practice, 21(8), Cd3\u2013Cd4.","journal-title":"Emergency Medicine Practice"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2016.1120718"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.199"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007557.pub3"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz405"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00592-4"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-9-200605020-00011"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002132"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2018.1517040"},{"key":"e_1_3_5_20_1","unstructured":"Medication Services Queensland. (2022). Anticoagulant guideline for hospitalised adult patients. State of Queensland. https:\/\/www.health.qld.gov.au\/__data\/assets\/pdf_file\/0015\/1152213\/statewide-anticoagulant-guideline.pdf."},{"key":"e_1_3_5_21_1","unstructured":"MIMS Online [Internet]. (2020). MIMS Australia. https:\/\/www.mimsonline.com.au\/Search\/FullPI.aspx?ModuleName=Product%20Info&searchKeyword=clexane&PreviousPage=~\/Search\/QuickSearch.aspx&SearchType=&ID=26580003_2."},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm224"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1L194"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.15420\/icr.2017:26:1"},{"key":"e_1_3_5_25_1","unstructured":"Queensland Health. (2020). Heparin intravenous infusion order and administration \u2013 Adult. State of Queensland. https:\/\/gchweb.sth.health.qld.gov.au\/documents\/CF000654."},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001100.pub4"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000119.pub4"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/1060028018768449"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000000336"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1315-2"},{"key":"e_1_3_5_31_1","unstructured":"Stroke Foundation. (2022). Clinical guidelines for stroke management. Stroke Foundation. Retrieved March 15 from https:\/\/files.magicapp.org\/guideline\/d0f7fe9e-ce05-4dbc-b41b-65d153bebc31\/published_guideline_6655-10_4.pdf."},{"key":"e_1_3_5_32_1","volume-title":"Therapeutic guidelines. Cardiovascular","author":"Therapeutic Guidelines","year":"2023","unstructured":"Therapeutic Guidelines. (2023). Therapeutic guidelines. Cardiovascular. Therapeutic Guidelines Ltd."},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50004"}],"container-title":["Journal of Pharmaceutical Policy and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/20523211.2024.2418367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T15:01:47Z","timestamp":1772722907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/20523211.2024.2418367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/20523211.2024.2418367"],"URL":"https:\/\/doi.org\/10.1080\/20523211.2024.2418367","relation":{},"ISSN":["2052-3211"],"issn-type":[{"value":"2052-3211","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,19]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=jppp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-05-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2418367"}}